Glenmark Pharmaceuticals has informed that it attached media release titled ‘: Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials’.
The above information is a part of company’s filings submitted to BSE.